SCHEMBL8551088

SCHEMBL8551088

c1ccc2c(CCN3CCC(c4cc(-c5ccc6c(c5)CCOO6)[nH]n4)CC3)c[nH]c2c1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.42
DRD2 P14416 3/20 0.41
HTR1A P08908 6/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
CYP2D6 P10635 1/20 0.38
DRD4 P21917 2/20 0.38
DRD3 P35462 2/20 0.38
DRD1 P21728 1/20 0.38
DRD5 P21918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8545428 0.87 ADRA1D (0.39) DRD2HTR1AADRA1DADRA1AADRA1B
SCHEMBL8551091 0.86 HTR1A (0.53) HTR2ADRD2HTR1AADRA2AADRA2B
SCHEMBL8917837 0.86 HTR1A (0.37) HTR2ADRD2HTR1ADRD4DRD3
SCHEMBL8545455 0.78 DRD2 (0.50) HTR2ADRD2HTR1AADRA2AADRA2B
SCHEMBL8545434 0.72 DRD2 (0.40) DRD2HTR1AADRA1DADRA1AADRA1B
SCHEMBL1388497 0.72 DRD2 (0.56) HTR2ADRD2HTR1AADRA2AADRA2B
SCHEMBL8546423 0.71 SNCA (0.42) DRD2HTR1AADRA1DADRA1AADRA1B
SCHEMBL8917850 0.71 HTR1A (0.40) HTR2ADRD2HTR1ADRD4DRD3
SCHEMBL8549889 0.69 SLC6A4 (0.44) DRD2HTR1AADRA1DADRA1AADRA1B
SCHEMBL6465788 0.68 HTR2A (0.88) HTR2ADRD2HTR1AADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0822814-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-12-09 EP claimed
EP-0822814-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-02-11 EP claimed
WO-1996032938-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-10-24 WO claimed
EP-0822814-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-12-09 EP disclosed
EP-0822814-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-02-11 EP disclosed
US-5668148-A BENIGN PROSTATIC HYPERTROPHY MERCK & CO., INC. (US) 1997-09-16 US disclosed
WO-1996032938-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-10-24 WO disclosed